RNA: From the messenger to the medicine
Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to Amber Tong.
In the 1990s, my colleagues and I were gene hunters. In the years before the human genome was fully sequenced, we searched tirelessly for the genetic roots of disease. It was a decades-long endeavor to first define a syndrome, then locate the responsible gene, determine its sequence, study its mutations and manipulate it for therapeutic benefit.
At the time, RNA science wasn’t being seriously considered. DNA was our star, and RNA was a bit player.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
